OrthoPediatricsKIDS
KIDS
About: OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Employees: 562
0
Funds holding %
of 7,296 funds
0
Analysts bullish %
of 5 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
500% more call options, than puts
Call options by funds: $12K | Put options by funds: $2K
75% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 12
7% more capital invested
Capital invested by funds: $383M [Q4 2024] → $411M (+$28.6M) [Q1 2025]
6% more funds holding
Funds holding: 108 [Q4 2024] → 115 (+7) [Q1 2025]
0.59% more ownership
Funds ownership: 68.13% [Q4 2024] → 68.72% (+0.59%) [Q1 2025]
8% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 38
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$24
13%
upside
Avg. target
$37
73%
upside
High target
$50
136%
upside
5 analyst ratings
4 positive
80%
1 neutral
20%
0 negative
0%
Piper Sandler Matt O'Brien | 42%upside $30 | Overweight Maintained | 8 May 2025 |
Needham Mike Matson | 98%upside $42 | Buy Reiterated | 8 May 2025 |
Truist Securities Richard Newitter | 13%upside $24 | Hold Maintained | 11 Apr 2025 |
Lake Street Ben Haynor | 75%upside $37 | Buy Initiated | 7 Apr 2025 |
Citizens Capital Markets David Turkaly | 136%upside $50 | Market Outperform Reiterated | 21 Mar 2025 |
Financial journalist opinion
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting
WARSAW, Ind., May 14, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the 2025 Pediatric Orthopaedic Society of North America (“POSNA”) annual meeting as an Emerald Sponsor.
Neutral
Seeking Alpha
1 month ago
OrthoPediatrics Corp. (KIDS) Q1 2025 Earnings Call Transcript
OrthoPediatrics Corp. (NASDAQ:KIDS ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group, IR David Bailey - President and CEO Fred Hite - Chief Operating and Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Ryan Zimmerman - BTIG Rick Wise - Stifel Ben Haynor - Lake Street Capital Markets Operator Good day and thank you for standing by. Welcome to the OrthoPediatrics Corporation First Quarter 2025 Earnings Conference call.
Positive
Zacks Investment Research
1 month ago
OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for OrthoPediatrics (KIDS) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Negative
Zacks Investment Research
1 month ago
OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.30 per share a year ago.
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025.
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System
WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its Trauma and Deformity portfolio with 3P™ Pediatric Plating Platform™ Hip System, the first of several systems in the 3P family. This represents the company's 5th FDA approval in 2025.
Neutral
GlobeNewsWire
1 month ago
OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025
WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2025 financial results on May 7, 2025 after the market closes.
Neutral
GlobeNewsWire
2 months ago
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
WARSAW, Ind., April 08, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat Early Onset Scoliosis (“EOS”). This represents the company's 80th system designed to treat musculoskeletal issues in children.
Neutral
GlobeNewsWire
2 months ago
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
WARSAW, Ind., March 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference.
Neutral
GlobeNewsWire
2 months ago
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana
WARSAW, Ind., March 24, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was selected as one of the 2025 Best Places to Work in Indiana. This is the 9th time the Company has been recognized by the annual program created by the Indiana Chamber of Commerce.
Charts implemented using Lightweight Charts™